Unknown

Dataset Information

0

Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.


ABSTRACT: Purpose: Histone deacetylase inhibitors (HDI) are promising anticancer therapies; however, drug resistance limits their efficacy. Here, we investigated the molecular mechanisms underlying HDI resistance, focusing on the mechanism of HDI-mediated induction of insulin-like growth factor 2 (IGF2) based on our previous study.Experimental Design: The methylation status of CCCTC-binding factor (CTCF)-binding sites in the IGF2/H19 imprinting control region (ICR) were determined by methylation-specific PCR and bisulfite sequencing. The effectiveness of single or combinatorial blockade of DNA methyltransferase 1 (DNMT1) and histone deacetylase (HDAC) was evaluated using cell viability assay and patient-derived tumor xenograft (PDX) model.Results: HDAC inhibition by vorinostat increased acetylated STAT3 (K685), resulting in transcriptional upregulation of DNMT1 DNMT1-mediated hypermethylation of CTCF-binding sites in the IGF2/H19 ICR decreased CTCF insulator activity, leading to a transcriptional upregulation of IGF2 and activation of the insulin-like growth factor 1 receptor (IGF-1R) pathway in cells with acquired or de novo vorinostat resistance. Strategies targeting DNMT1 diminished the IGF2 expression and potentiated vorinostat sensitivity in preclinical models of lung cancer with hypermethylation in the H19/IGF2 ICR. The degree of ICR hypermethylation correlated with vorinostat resistance in patient-derived lung tumors and in patients with hematologic malignancies.Conclusions: DNMT1-mediated transcriptional upregulation of IGF2 is a novel mechanism of resistance to HDIs, highlighting the role of epigenetic deregulation of IGF2 in HDI resistance and the potential value of the H19/IGF2 ICR hypermethylation and DNMT1 expression as predictive biomarkers in HDI-based anticancer therapies. Clin Cancer Res; 23(5); 1299-311. ©2016 AACR.

SUBMITTER: Min HY 

PROVIDER: S-EPMC5340567 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.

Min Hye-Young HY   Lee Su-Chan SC   Woo Jong Kyu JK   Jung Hyun Jin HJ   Park Kwan Hee KH   Jeong Hae Min HM   Hyun Seung Yeob SY   Cho Jaebeom J   Lee Wooin W   Park Ji Eun JE   Kwon So Jung SJ   Lee Hyo-Jong HJ   Ni Xiao X   Shin Young Kee YK   Johnson Faye M FM   Duvic Madeleine M   Lee Ho-Young HY  

Clinical cancer research : an official journal of the American Association for Cancer Research 20160831 5


<b>Purpose:</b> Histone deacetylase inhibitors (HDI) are promising anticancer therapies; however, drug resistance limits their efficacy. Here, we investigated the molecular mechanisms underlying HDI resistance, focusing on the mechanism of HDI-mediated induction of insulin-like growth factor 2 (IGF2) based on our previous study.<b>Experimental Design:</b> The methylation status of CCCTC-binding factor (CTCF)-binding sites in the <i>IGF2/H19</i> imprinting control region (ICR) were determined by  ...[more]

Similar Datasets

| S-EPMC5069101 | biostudies-literature
| S-EPMC9181358 | biostudies-literature
| S-EPMC3627058 | biostudies-literature
| S-EPMC5808772 | biostudies-literature
| S-EPMC5891791 | biostudies-literature
| S-EPMC2581551 | biostudies-literature
| S-EPMC5527463 | biostudies-other
| S-EPMC2593472 | biostudies-other
| S-EPMC7594386 | biostudies-literature
| S-EPMC3261307 | biostudies-literature